Use of gelsolin to treat infections

Details for Australian Patent Application No. 2005244865 (hide)

Owner The Brigham and Women's Hospital, Inc.

Inventors Stossel, Thomas, P.; Lee, Po-Shun

Agent Davies Collison Cave

Pub. Number AU-A-2005244865

PCT Pub. Number WO2005/112970

Priority 60/570,233 12.05.04 US

Filing date 12 May 2005

Wipo publication date 1 December 2005

International Classifications

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/012 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/018 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/112970 Priority application(s): WO2005/112970

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244867-Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor

2005244856-Controlled dispersion multi-phase nozzle and method of making the same